Join the COVID-19 group to help and get support from people like you.
COVID-19 News (Page 17)
Related terms: 2019-nCoV, 2019 Novel Coronavirus, Coronavirus, SARS-CoV-2 Infection, Novel Coronavirus Pneumonia
Genentech’s Actemra Receives FDA Emergency Use Authorization for the Treatment of COVID-19 In Hospitalized Adults and Children
South San Francisco, CA – June 24, 2021 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has issued an...
High Vitamin D Levels May Help Prevent COVID-19, Especially in Black Patients
FRIDAY, March 19, 2021 – Vitamin D – better known as the "sunshine vitamin" – might protect you from COVID-19, a new study suggests. Researchers said that the protection is particularly potent...
Obesity a Big Risk Factor for Severe COVID-19, Study Confirms
MONDAY, March 8, 2021 – Yet another study confirms what doctors have long known: Being obese greatly raises the odds that if you contract COVID-19, your case could be a severe one. The study, from...
FDA Approves Veklury (remdesivir) for the Treatment of COVID-19
FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct. 22, 2020-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury...
FDA Medwatch Alert: Remdesivir by Gilead Sciences: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of Treatment
ISSUE: FDA is warning health care providers that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral...
Much Needed Rapid Diagnostic Test, Xpert Xpress SARS-CoV-2, Authorized
Emergency Use Authorization (EUA) has been granted by the Food and Drug Administration (FDA) for California-based Cepheid’s, Xpert Xpress SARS-CoV-2 test. This is the first coronavirus test that can b...
Gilead Halts Remdesivir Access for COVID-19 Amid Other U.S. Drug Shortages
Gilead Halts Remdesivir Access for COVID-19 Amid Other U.S. Drug Shortages March 23, 2020 - Leigh Ann Anderson, PharmD In a jarring headline on Sunday, Gilead Sciences Inc. announced a temporary...
Chloroquine and Hydroxychloroquine Under Investigation for COVID-19
US to conduct clinical trials of chloroquine for COVID-19 Clinical trials of chloroquine and its less toxic metabolite, hydroxychloroquine, are ongoing or due to start in other countries. Both drugs...
Blood Type May Affect COVID-19 Risk: Study
A person's blood type may affect their risk for COVID-19, the disease caused by the new coronavirus, researchers report. They analyzed blood samples from nearly 2,200 COVID-19 patients in China and...
CureVac’s Coronavirus Vaccine at the Center of a Fight for Control
CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...
Preventing COVID-19 Spread in Communities
Protect yourself and your community from getting and spreading respiratory illnesses like coronavirus disease 2019. Everyone has a role to play in getting ready and staying healthy. Americans should ...